Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS) (VEGF-ARDS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01314066
Recruitment Status : Withdrawn (No funding)
First Posted : March 14, 2011
Last Update Posted : May 3, 2016
Information provided by (Responsible Party):
Weill Medical College of Cornell University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : November 2015
  Estimated Study Completion Date : February 2016